Case Report: Rare gastric and bone metastases after early endocrine therapy discontinuation in hormone receptor-positive breast cancer: lessons and therapeutic insights. [PDF]
Front OncolLu M, Hu G, Shen Q.
europepmc +1 more source
Investigating radiotherapy's impact on intestinal perforation risk in gastrointestinal tumor patients treated with bevacizumab. [PDF]
World J Gastrointest OncolHe WM, Li WS.
europepmc +1 more source
Predicting response to neoadjuvant therapy in breast cancer using longitudinal DCE-MRI deep learning integrated with tumor microenvironment data. [PDF]
Front ImmunolYan L +8 more
europepmc +1 more source
Development and validation of nomograms of outcomes for first-line platinum-based chemotherapy for metastatic triple-negative breast cancer: patient-level analysis of five prospective clinical trials in China. [PDF]
Ther Adv Med OncolGong C +10 more
europepmc +1 more source
Clinical efficacy of CT-guided iodine-125 seed brachytherapy in unresectable locoregionally recurrent breast cancer. [PDF]
J Contemp BrachytherapyJi L, Zhang W, Hao S, Wang Z, Zhang G.
europepmc +1 more source
Tumor markers level profile in dermatomyositis, systemic sclerosis, systemic lupus erythematosus, rheumatoid arthritis and ovarian cancer. [PDF]
Eur J Med ResCai JC +7 more
europepmc +1 more source
Comment on 'the impact of body mass index on the efficacy of CDK4/6 inhibitors in patients with metastatic breast cancer'. [PDF]
Ann MedChen X, Gu S, Ding S.
europepmc +1 more source
Regarding: "the impact of body mass index on the efficacy of CDK4/6 inhibitors in patients with metastatic breast cancer". [PDF]
Ann MedLi D, Sun C, Wang C.
europepmc +1 more source
A dual-signal-amplified electrochemical biosensor for sensitive and accurate detection of cancer cells. [PDF]
RSC AdvWu Y, Wang Y, He R, Li Y, Ben Y.
europepmc +1 more source
Vasculogenic mimicry and breast cancer prognosis: Insights into predictive model development. [PDF]
Oncol LettWu Z +7 more
europepmc +1 more source